Gameto has raised a $20 million Series A led by Future Ventures, PitchBook reports. The New York-based company is developing ovarian therapeutics intended to improve fertility and help women manage the impact of menopause. Additional investors included Bold Capital Partners, Lux Capital, Overwater Ventures, Plum Alley Investments, TA Ventures. Read more.
Femtech Startup Gameto Lands $20M
